Here are five observations:
1. NeuroMetrix’s revenue is expected to be up in the fourth quarter from $2.1 million in the third quarter.
2. The company shipped 6,675 Quell devices in the fourth quarter, up from 4,514 Quell devices in the third quarter.
3. NeuroMetrix estimates its 2015 full year revenue will reach $7.3 million, compared to $5.5 million in 2014.
4. The company believes it shipped about 13,800 Quell devices in 2015.
5. By the end of 2015, the company had $12.4 million in cash and cash equivalents.
More articles on devices:
Nanotherapeutics grants worldwide license to Amend Surgical for bone void filler: 5 notes
Moody’s: 3 important insights into the orthopedic device industry in 2016
MiMedx buys Stability Biologics — 5 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
